Apple sues China's Oppo, ex-engineer over alleged theft of Watch secrets
Apple accused smartphone maker Oppo in a lawsuit of poaching a highly paid member of the Apple Watch team and encouraging him to steal trade secrets for his new job with the Chinese firm. Sensor system architect Chen Shi secretly accessed confidential documents on Apple's health-sensing ...
The Journey to Building a Future-Ready Finance Function at Hindustan Unilever Limited
Ritesh Tiwari, CFO of Hindustan Unilever Limited, explains how finance must evolve from being a custodian of numbers to a driver of business value. Can technology and culture together future-proof the function? And are finance professionals ready to lead transformation?
$1000 Invested In Encompass Health 15 Years Ago Would Be Worth This Much Today - Encompass Health ( NYSE:EHC )
Encompass Health EHC has outperformed the market over the past 15 years by 3.22% on an annualized basis producing an average annual return of 16.07%. Currently, Encompass Health has a market capitalization of $12.39 billion.
Why Biohaven Stock Zoomed More Than 6% Higher Today
It's always encouraging to get what appears to be good news from the FDA.
Here's How Much You Would Have Made Owning Gilead Sciences Stock In The Last 20 Years - Gilead Sciences ( NASDAQ:GILD )
Gilead Sciences GILD has outperformed the market over the past 20 years by 4.08% on an annualized basis producing an average annual return of 12.81%. Currently, Gilead Sciences has a market capitalization of $142.44 billion.
Kirby McInerney LLP Announces Investigation Against AVITA Medical, Inc. on Behalf of Investors - AVITA Medical ( NASDAQ:RCEL )
NEW YORK, Aug. 22, 2025 ( GLOBE NEWSWIRE ) -- The law firm of Kirby McInerney LLP is investigating potential claims against AVITA Medical, Inc. ( "AVITA" or the "Company" ) RCEL. The investigation concerns whether AVITA and/or certain of its officers have violated the federal securities laws ...
Kirby McInerney LLP Announces Investigation Against Lantheus Holdings, Inc. on Behalf of Investors - Lantheus Holdings ( NASDAQ:LNTH )
NEW YORK, Aug. 22, 2025 ( GLOBE NEWSWIRE ) -- The law firm of Kirby McInerney LLP is investigating potential claims against Lantheus Holdings, Inc. ( "Lantheus" or the "Company" ) LNTH. The investigation concerns whether Lantheus and/or certain of its officers have violated the federal ...
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635 ( c ) ( 4 ) - Iovance Biotherapeutics ( NASDAQ:IOVA )
SAN CARLOS, Calif., Aug. 22, 2025 ( GLOBE NEWSWIRE ) -- Iovance Biotherapeutics, Inc.
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635 ( c ) ( 4 )
SAN CARLOS, Calif., Aug. 22, 2025 ( GLOBE NEWSWIRE ) -- Iovance Biotherapeutics, Inc. ( NASDAQ: IOVA ) ( "Iovance" or the "Company" ) , a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte ( "TIL" ) therapies for patients with ...
Lost Money on Novo Nordisk A/S ( NVO ) ? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky - Novo Nordisk ( NYSE:NVO )
NEW YORK, Aug. 22, 2025 ( GLOBE NEWSWIRE ) -- Levi & Korsinsky, LLP notifies investors in Novo Nordisk A/S ( "Novo" or the "Company" ) NVO of a class action securities lawsuit.
Lost Money on RxSight, Inc. ( RXST ) ? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky - RxSight ( NASDAQ:RXST )
NEW YORK, Aug. 22, 2025 ( GLOBE NEWSWIRE ) -- Levi & Korsinsky, LLP notifies investors in RxSight, Inc. ( "RxSight, Inc." or the "Company" ) RXST of a class action securities lawsuit.
Capricor Therapeutics, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before September 15, 2025 to Discuss Your Rights - CAPR - Capricor Therapeutics ( NASDAQ:CAPR )
NEW YORK, Aug. 22, 2025 ( GLOBE NEWSWIRE ) -- Levi & Korsinsky, LLP notifies investors in Capricor Therapeutics, Inc. ( "Capricor" or the "Company" ) CAPR of a class action securities lawsuit.
Lost Money on Replimune Group, Inc. ( REPL ) ? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky - Replimune Group ( NASDAQ:REPL )
NEW YORK, Aug. 22, 2025 ( GLOBE NEWSWIRE ) -- Levi & Korsinsky, LLP notifies investors in Replimune Group, Inc. ( "Replimune Group, Inc." or the "Company" ) REPL of a class action securities lawsuit.
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 14, 2025 in Unicycive Therapeutics, Inc. Lawsuit - UNCY - Unicycive Therapeutics ( NASDAQ:UNCY )
NEW YORK, Aug. 22, 2025 ( GLOBE NEWSWIRE ) -- Levi & Korsinsky, LLP notifies investors in Unicycive Therapeutics, Inc. ( "Unicycive Therapeutics, Inc." or the "Company" ) UNCY of a class action securities lawsuit.
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of September 16, 2025 in Neogen Corporation Lawsuit - NEOG - Neogen ( NASDAQ:NEOG )
NEW YORK, Aug. 22, 2025 ( GLOBE NEWSWIRE ) -- Levi & Korsinsky, LLP notifies investors in Neogen Corporation ( "Neogen Corporation" or the "Company" ) NEOG of a class action securities lawsuit.
TeraWulf Inc. Announces Full Exercise of Greenshoe Option in $1.0 Billion Convertible Senior Notes Offering
EASTON, Md., Aug. 22, 2025 ( GLOBE NEWSWIRE ) -- TeraWulf Inc. ( Nasdaq: WULF ) ( "TeraWulf" or the "Company" ) , a leading owner and operator of vertically integrated, predominantly zero-carbon digital infrastructure, today announced that the initial purchasers of 1.00% Convertible Senior Notes ...
Price Over Earnings Overview: Pfizer - Pfizer ( NYSE:PFE )
Looking into the current session, Pfizer Inc. PFE shares are trading at $25.84, after a 0.39% increase. Moreover, over the past month, the stock spiked by 4.24%, but in the past year, fell by 10.65%.
$1000 Invested In Eli Lilly 15 Years Ago Would Be Worth This Much Today - Eli Lilly ( NYSE:LLY )
Eli Lilly LLY has outperformed the market over the past 15 years by 9.64% on an annualized basis producing an average annual return of 22.48%. Currently, Eli Lilly has a market capitalization of $637.57 billion.
Are Options Traders Betting on a Big Move in Esperion Therapeutics Stock?
Investors need to pay close attention to Esperion Therapeutics stock based on the movements in the options market lately.
TeraWulf's Bold Moves Transform It Into Top US Data Center Player - TeraWulf ( NASDAQ:WULF )
TeraWulf completed an $850M convertible notes offering, netting $828.7M with part allocated to capped call transactions. Google's 14% stake and Fluidstack's 160 MW expansion option strengthen TeraWulf's position in U.S. HPC data centers. See the seasonal trading strategy that's beating the S&P ...
NVCR Stock Slips Despite PMA Application to Treat Pancreatic Cancer
NovoCure submits a PMA to the FDA for TTFields therapy in pancreatic cancer, aiming to expand its oncology reach.
Moderna Stock Is Trading Higher Friday: What's Going On? - Moderna ( NASDAQ:MRNA )
Health Canada approves Moderna's updated Spikevax vaccine targeting the LP.8.1 variant for individuals six months and older. All pre-filled syringe doses for Canada are produced domestically for the first time, with Canadian-made supply available this fall. The market is reacting to Powell's ...
UK Drug Pricing Talks Collapse, Drugmakers Reject Offer Citing 'Uncompetitive' System - AstraZeneca ( NASDAQ:AZN ) , Novartis ( NYSE:NVS )
UK drug rebate system takes back 23% of sales above budget cap, nearly triple EU levels. The government's plan to double the share of medicine spending in GDP has been delayed until 2029. See the 6X seasonal strategy set to target this fall's biggest opportunities. Details here →
Is ANI ( ANIP ) a Solid Growth Stock? 3 Reasons to Think "Yes"
ANI (ANIP) is well positioned to outperform the market, as it exhibits above-average growth in financials.
INVESTOR ALERT: Investigation of AVITA Medical, Inc. ( RCEL ) Announced by Holzer & Holzer, LLC - AVITA Medical ( NASDAQ:RCEL )
ATLANTA, Aug. 22, 2025 ( GLOBE NEWSWIRE ) -- Holzer & Holzer, LLC is investigating whether AVITA Medical, Inc. ( "AVITA" or the "Company" ) RCEL complied with federal securities laws.
$1000 Invested In Danaher 10 Years Ago Would Be Worth This Much Today - Danaher ( NYSE:DHR )
Danaher DHR has outperformed the market over the past 10 years by 1.07% on an annualized basis producing an average annual return of 13.56%. Currently, Danaher has a market capitalization of $151.72 billion.
Replimune ( REPL ) Faces Securities Class Action Following Stock's Collapse Amid FDA's Rejection of Melanoma Drug - Hagens Berman - Replimune Group ( NASDAQ:REPL )
SAN FRANCISCO, Aug. 22, 2025 ( GLOBE NEWSWIRE ) -- A new securities class action has been initiated against Replimune Group, Inc. REPL and certain executives, arising out of the company's recent stock price collapse. The lawsuit, officially known as Jboor v. Replimune Group, Inc., et al., No. ...
SRPT 3-DAY DEADLINE ALERT: Hagens Berman Urges Sarepta Investors to Act Before August 25 Deadline - Sarepta Therapeutics ( NASDAQ:SRPT )
SAN FRANCISCO, Aug. 22, 2025 ( GLOBE NEWSWIRE ) -- A securities class-action lawsuit is underway against Sarepta Therapeutics SRPT, triggered by a series of safety concerns and regulatory setbacks for its gene therapy, ELEVIDYS. The lawsuit alleges that Sarepta misled investors by presenting ...
Kodak CEO Says There's 'Substantial Doubt' About Whether Or Not The 133-Year-Old Company Will Continue - Eastman Kodak ( NYSE:KODK )
The Eastman Kodak Company KODK is warning investors that it may not exist for much longer. The 133-year-old photography company pointed to ongoing struggles to satisfy its debt obligations, which have left the company with "substantial doubt about [its] ability to continue," as the primary reason ...
Why Johnson & Johnson ( JNJ ) is a Great Dividend Stock Right Now
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes? Let's find out.
ROSEN, NATIONAL INVESTOR RIGHTS COUNSEL, Encourages Replimune Group, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - REPL - Replimune Group ( NASDAQ:REPL )
NEW YORK, Aug. 22, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Replimune Group, Inc.
ROSEN, A TOP-RANKED LAW FIRM, Encourages Novo Nordisk A/S Investors to Secure Counsel Before Important Deadline in Securities Class Action - NVO - Novo Nordisk ( NYSE:NVO )
NEW YORK, Aug. 22, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Novo Nordisk A/S NVO between May 7, 2025 and July 28, 2025, both dates inclusive ( the "Class Period" ) , of the important September 30, 2025 lead ...
ROSEN, SKILLED INVESTOR COUNSEL, Encourages RxSight, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - RXST - RxSight ( NASDAQ:RXST )
NEW YORK, Aug. 22, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of RxSight, Inc. RXST between November 7, 2024 and July 8, 2025, both dates inclusive ( the "Class Period", of the important September 22, 2025 lead plaintiff ...
Why Recursion Pharmaceuticals Stock Caught a Cold This Week
The few news items from and about the company weren't all that positive.
Tevogen Recognized in BINJE's BEST Health Care 2025 for Advancing Health Equity and Sustainable Biopharma
WARREN, N.J., Aug. 22, 2025 ( GLOBE NEWSWIRE ) -- Tevogen Bio Holdings Inc. ( "Tevogen" or the "Company" ) ( Nasdaq: TVGN ) , announced today that it has been named in BINJE's BEST Health Care 2025: Companies, Organizations and Service Providers.
A Closer Look at Alnylam Pharmaceuticals's Options Market Dynamics - Alnylam Pharmaceuticals ( NASDAQ:ALNY )
Financial giants have made a conspicuous bullish move on Alnylam Pharmaceuticals. Our analysis of options history for Alnylam Pharmaceuticals ALNY revealed 10 unusual trades. Delving into the details, we found 50% of traders were bullish, while 30% showed bearish tendencies.
What's Going With Dialysis Firm DaVita Stock On Friday? - DaVita ( NYSE:DVA )
Ransomware breach exposed 2.7 million DaVita patients' personal and health data. DaVita Q2 EPS of $2.95 beats $2.79 estimate; $2 billion share buyback approved. The market is reacting to Powell's speech. Learn how to time your next move. Details here →
Procter & Gamble Options Trading: A Deep Dive into Market Sentiment - Procter & Gamble ( NYSE:PG )
Financial giants have made a conspicuous bullish move on Procter & Gamble. Our analysis of options history for Procter & Gamble PG revealed 8 unusual trades. Delving into the details, we found 50% of traders were bullish, while 37% showed bearish tendencies.
BWAY Shares Rise on Strategic Investment in Neurolief's At-Home Care
BrainsWay's $5 million investment in Neurolief expands its mental health footprint with at-home depression treatment potential.
Interpol coordinates crackdown on illegal Angola-based crypto miners
A mining ban went into effect in the African nation in April 2024, followed by Chinese officials warning residents not to "support or engage in virtual currency mining activities." ...
CNC Investor Update: Lawsuit Filed Against Centene ( CNC ) Over Enrollment - Hagens Berman - Centene ( NYSE:CNC )
SAN FRANCISCO, Aug. 22, 2025 ( GLOBE NEWSWIRE ) -- A securities class-action lawsuit has been filed against Centene Corporation CNC, a major provider of healthcare services. The lawsuit, captioned Lunstrum v.
Public Keys: Ethereum Treasuries Soar, Bitcoin ETFs' $1 Billion Bleed, Crypto IPO Chatter
Fed hints spark crypto rally as Bitcoin ETFs bleed $1B, but Ethereum bounces back. Plus, Figure Technologies is eyeing an IPO.
This Netgear Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Friday - Immunome ( NASDAQ:IMNM ) , Dorman Products ( NASDAQ:DORM )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Wells Fargo analyst David Lantz initiated coverage on Dorman Products, Inc.
Coinbase, Strategy Lead Crypto Stock Rebound as Bitcoin and Ethereum Soar
Crypto-related stocks, like Bitcoin treasuries and exchanges, rose Friday following dovish talk from Federal Reserve Chair Jerome Powell.
DEADLINE ALERT for HIMS, IRBT, CNC, BHVN: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions - Biohaven ( NYSE:BHVN ) , Centene ( NYSE:CNC )
BENSALEM, Pa., Aug. 22, 2025 ( GLOBE NEWSWIRE ) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.
Short-Term Pain, Long-Term Gain? 4 Quantum Stocks to Watch
IonQ, D-Wave, Rigetti and QUBT report steep Q2 losses but strengthen cash positions with major fundraising to fuel quantum growth.
Workday Q2 Earnings Beat Estimates on Solid Revenue Growth
WDAY posts strong second-quarter results with revenues and earnings topping estimates, fueled by customer wins and solid subscription growth.
Warren Buffett Makes a Big Buy
Berkshire Hathaway bought $1.6 billion of United Health stock in Q2. Inflation may be ticking higher after all.
Nasdaq Jumps 2%; Workday Shares Fall Following Q2 Results - BJ's Wholesale Club Hldgs ( NYSE:BJ ) , EpicQuest Education Group ( NASDAQ:EEIQ )
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 2% on Friday. The Dow traded up 1.91% to 45,642.89 while the NASDAQ rose 1.96% to 21,513.52. The S&P 500 also rose, gaining, 1.55% to 6,468.68. Consumer discretionary shares jumped by 3.3% on Friday.
Deal Dispatch: Musk-Altman Drama, Ashton Kutcher SoHo House Play And We Pose Questions To Private Equity Pros - Cenovus Energy ( NYSE:CVE )
OpenAI isn't for sale. However, a $97.4 billion offer is hard to ignore. That's the number Elon Musk asked fellow billionaire Mark Zuckerberg to help him reach to buy the parent company of ChatGPT. Neither Zuckerberg nor Meta Platforms, Inc. META ultimately signed a letter of intent.
